Page 1 of Clinical Trials for Drug fluticasone salmeterol 250 50, 45 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study
Last Updated: February 2, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
2
Completed
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Last Updated: December 17, 2010
Condition(s): Asthma
3
Not yet recruiting
Comparing Fluticasone-Salmeterol in Chronic Obstructive Pulmonary Disease (COPD) and Sleep
Last Updated: August 8, 2008
Condition(s): COPD
4
Completed
Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population
Last Updated: June 16, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
5
Recruiting
6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old
Last Updated: May 10, 2012
Condition(s): Asthma
6
Recruiting
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.
Last Updated: May 10, 2012
Condition(s): Asthma
7
Completed
A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: December 16, 2010
Condition(s): CV Risk; Pulmonary Disease, Chronic Obstructive; Chronic Bronchitis; Chronic Obstructive Pulmonary Disease (COPD); Cardiovascular Disease; Smoking; Emphysema
8
Completed
Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease
Last Updated: November 23, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
9
Active, not recruiting
Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID
Last Updated: January 30, 2006
Condition(s): Asthma; Candidiasis, Oral; Voice Disorders
10
Completed
A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS 250/50mcg Plus SPIRIVA HANDIHALER Versus SPIRIVA HANDIHALER Plus Placebo DISKUS in Subjects With Chronic Obstructive Pulmonary Disease (COPD). SPIRIVA and HANDIHALER Are Trade Marks of Boehringer Ingelheim
Last Updated: May 17, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
11
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
12
Active, not recruiting
Evaluation Inhaled Corticosteroids on Exhaled Nitric Oxide Gas Exchange
Last Updated: July 13, 2011
Condition(s): COPD
13
Completed
Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease
Last Updated: January 22, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease
14
Completed
Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for Asthma
Last Updated: April 12, 2012
Condition(s): Asthma
15
Completed
Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139AM1)(COMPLETED)
Last Updated: October 26, 2010
Condition(s): Asthma
16
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg Twice Daily To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg Twice Daily In Symptomatic Patients With Asthma
Last Updated: May 5, 2011
Condition(s): Asthma
17
Completed
A 12-Month Study Comparing Fluticasone Propionate/Salmeterol (ADVAIR) DISKUS Combination Product 250/50mcg BID To Fluticasone Propionate (FLOVENT) DISKUS 250 Mcg BID In Symptomatic Subjects With Asthma
Last Updated: November 10, 2011
Condition(s): Asthma
18
Completed
The Effect of Fluticasone/Salmeterol Combination on Exertional Breathlessness in Patients With Mild COPD
Last Updated: January 18, 2012
Condition(s): COPD
19
Completed
Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: September 15, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive
20
Recruiting
Long-acting Beta Agonist Step Down Study
Last Updated: May 10, 2012
Condition(s): Asthma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+fluticasone+salmeterol+250+50

Page 1 of Clinical Trials for Drug fluticasone salmeterol 250 50, 45 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About